Unfortunately, it’s not fantasy land. Here’s some information for you.
Evidence to Support an Ongoing FBI Investigation
Here’s evidence to support posts that state the FBI is currently questioning shareholders:
1. Last year and earlier this year, investors posted two different FOIAs from the FDA regarding CYDY that were rejected for the reason below. That was the first warning.
“I can neither confirm nor deny the existence of records that would be responsive to your request. If they exist, records of this nature would be exempt from disclosure under FOIA exemption(b)(7)(a). Exemption (b)(7)(a) requires withholding of information complied for law enforcement purposes when disclosure could reasonably be expected to interfere with enforcement proceedings.”
2. CYDY 10K from July, 30th, 2021. Note that the SEC/DOJ are looking into statements by the company, NOT shorts, bashers, Adam F, the 13d, etc.
“The Company has received subpoenas from the United States Securities and Exchange Commission requesting documents and information concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19 and related communications with the FDA, investors, and others, and trading in the securities of CytoDyn. The SEC has informed the Company that this inquiry should not be construed as an indication that any violations of law have occurred or that the SEC has any negative opinion of any person, entity or securities trading activity.
In addition, the Company and certain of its executives have received subpoenas in connection with an investigation being conducted by the United States Department of Justice. The subpoenas seek testimony and/or records concerning, among other matters, leronlimab, the Company’s public statements regarding the use of leronlimab as a potential treatment for COVID-19 and related communications with the FDA, investors, and others, and trading in the securities of CytoDyn.
The Company is cooperating fully with these non-public, fact-finding investigations, and as of the date of this filing, the Company is unable to predict the ultimate outcome and cannot reasonably estimate the potential possible loss or range of loss, if any.”
3. Stocktwits post revealing that a shareholder was contacted by the FBI in early October. Note that this specific poster is not a basher and has historically been positive about CYDY.
Bdfr 10/3/21 9:58pm “$CYDY I am saying this because I have nothing to hide nor have I any inside information. My friend has been asked about CYDY by the FBI. He has less shares than I have. They probed about how and why he is invested in CYDY. I have 19000 shares. I do not know what this means but I thought I should pass this along. That is all for now. I know I bull shit a lot but I have no idea why they would call him. Anyways, just a heads up.”
4. CYDY 10Q from October 12th, 2021, with the same blurb as the 10k. Note that at one point between the 10k and 10q, NP made a comment that they didn’t think they needed to disclose the SEC/DOJ investigation in the 10k. Well, apparently that was incorrect as they included in the 10q.
Conclusion: The FBI is questioning shareholders in regards to CYDY. They appear to be assessing the damage that NP inflicted by allegedly misleading shareholders about the status of the BLA (SP increased around $.75-1) only to later receive an RTF (SP dropped $1). What will come of this? We might find out soon.
News 
Market Data 
Discover 
AI
